These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement. Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279 [TBL] [Abstract][Full Text] [Related]
5. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine. Savi P; Laplace MC; Maffrand JP; Herbert JM J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545 [TBL] [Abstract][Full Text] [Related]
6. In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin. Rand ML; Gross PL; Jakowec DM; Packham MA; Mustard JF Thromb Haemost; 1989 Apr; 61(2):254-8. PubMed ID: 2546284 [TBL] [Abstract][Full Text] [Related]
7. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1. Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608 [TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro. Weber AA; Reimann S; Schrör K Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233 [TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation]. Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607 [TBL] [Abstract][Full Text] [Related]
10. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets. Lee H; Paton RC; Ruan C; Caen JP Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089 [TBL] [Abstract][Full Text] [Related]
11. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146 [TBL] [Abstract][Full Text] [Related]
12. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets. Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345 [TBL] [Abstract][Full Text] [Related]
13. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302 [TBL] [Abstract][Full Text] [Related]
14. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb. Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of ticlopidine: relation between dose and time of administration to platelet inhibition. Kuzniar J; Splawinska B; Malinga K; Mazurek AP; Splawinski J Int J Clin Pharmacol Ther; 1996 Aug; 34(8):357-61. PubMed ID: 8864800 [TBL] [Abstract][Full Text] [Related]
16. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood. Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115 [TBL] [Abstract][Full Text] [Related]
17. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN. Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653 [TBL] [Abstract][Full Text] [Related]
18. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation. Peerschke EI J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399 [TBL] [Abstract][Full Text] [Related]
19. Changes of rabbit platelet function on simultaneous administration of ticlopidine hydrochloride and OKY-046. Kosugi T; Nakamura M; Saitoh S; Kinjoh K Int J Tissue React; 1991; 13(3):123-9. PubMed ID: 1960013 [TBL] [Abstract][Full Text] [Related]
20. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]